Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,411 | 407 | 99.6% |
| Education | $27.95 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $854.20 | 34 | $0 (2022) |
| Lilly USA, LLC | $640.95 | 39 | $0 (2024) |
| Novo Nordisk Inc | $576.30 | 47 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $561.66 | 42 | $0 (2024) |
| ABBVIE INC. | $545.30 | 21 | $0 (2024) |
| PFIZER INC. | $495.88 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $458.09 | 24 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $430.05 | 15 | $0 (2018) |
| GlaxoSmithKline, LLC. | $418.90 | 23 | $0 (2024) |
| Amgen Inc. | $293.83 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $613.14 | 33 | AstraZeneca Pharmaceuticals LP ($98.79) |
| 2023 | $671.21 | 37 | GlaxoSmithKline, LLC. ($331.94) |
| 2022 | $1,058 | 52 | Lilly USA, LLC ($180.36) |
| 2021 | $803.28 | 55 | Janssen Pharmaceuticals, Inc ($136.61) |
| 2020 | $308.00 | 21 | Amgen Inc. ($59.44) |
| 2019 | $916.21 | 45 | SANOFI-AVENTIS U.S. LLC ($213.55) |
| 2018 | $1,099 | 68 | Novo Nordisk Inc ($172.42) |
| 2017 | $1,970 | 99 | Merck Sharp & Dohme Corporation ($407.99) |
All Payment Transactions
410 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.52 | General |
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: GI | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Bone Health | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Obesity | ||||||
| 08/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Bone Health | ||||||
| 08/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: UROLOGY | ||||||
| 07/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Endocrinology | ||||||
| 05/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: DIABETES | ||||||
| 05/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: PSYCHIATRY | ||||||
| 04/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: PAIN | ||||||
| 04/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 265 | 424 | $48,720 | $22,777 |
| 2022 | 9 | 300 | 466 | $52,925 | $25,707 |
| 2021 | 8 | 219 | 286 | $30,740 | $17,427 |
| 2020 | 17 | 796 | 1,295 | $118,565 | $46,093 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 156 | $31,200 | $13,760 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 56 | $7,000 | $3,565 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $3,300 | $2,854 | 86.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 19 | $1,805 | $864.50 | 47.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 27 | 50 | $1,250 | $466.48 | 37.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 14 | $900.00 | $378.42 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $312.50 | 81.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 11 | 11 | $660.00 | $219.00 | 33.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 27 | 54 | $1,080 | $170.13 | 15.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $780.00 | $129.03 | 16.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 18 | $360.00 | $57.97 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 149 | $28,020 | $12,516 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 48 | 48 | $7,200 | $6,337 | 88.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 90 | $11,250 | $4,983 | 44.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 17 | $1,615 | $660.45 | 40.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 24 | 40 | $1,000 | $383.62 | 38.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 15 | 16 | $800.00 | $367.53 | 45.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 23 | $1,380 | $188.08 | 13.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 31 | 56 | $1,120 | $178.08 | 15.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 27 | $540.00 | $92.38 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 117 | $21,060 | $12,310 | 58.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 42 | $5,250 | $3,121 | 59.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 12 | 12 | $840.00 | $797.16 | 94.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 21 | 21 | $735.00 | $362.88 | 49.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 14 | 14 | $560.00 | $270.34 | 48.3% |
About Dr. David Cooley, DO
Dr. David Cooley, DO is a Family Medicine healthcare provider based in Dearborn Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528025871.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Cooley, DO has received a total of $7,439 in payments from pharmaceutical and medical device companies, with $613.14 received in 2024. These payments were reported across 410 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,411).
As a Medicare-enrolled provider, Cooley has provided services to 1,580 Medicare beneficiaries, totaling 2,471 services with total Medicare billing of $112,004. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Dearborn Heights, MI
- Active Since 04/28/2006
- Last Updated 06/10/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1528025871
Products in Payments
- JARDIANCE (Drug) $362.22
- XARELTO (Drug) $349.10
- ELIQUIS (Drug) $334.98
- SOLIQUA (Drug) $305.40
- TRULICITY (Drug) $240.21
- CHANTIX (Drug) $237.69
- NURTEC ODT (Drug) $228.77
- BELSOMRA (Drug) $228.51
- INVOKANA (Drug) $212.56
- ENTRESTO (Drug) $191.58
- TOUJEO (Drug) $190.70
- AREXVY (Drug) $161.48
- EMGALITY (Drug) $157.27
- EVENITY (Biological) $157.02
- UBRELVY (Drug) $140.14
- SOLIQUA 100/33 (Drug) $139.03
- TRELEGY ELLIPTA (Drug) $132.68
- Creon (Drug) $130.47
- SOLIQUA 100/33 (Biological) $127.52
- Ozempic (Drug) $122.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dearborn Heights
Dr. Naiff Ali, M.d, M.D
Family Medicine — Payments: $9,718
Dr. George Elias, D.o, D.O
Family Medicine — Payments: $5,663
Dr. Deborah Kay
Family Medicine — Payments: $1,617
Dr. Randy Kay
Family Medicine — Payments: $1,346
Lynda Rayos, Do, DO
Family Medicine — Payments: $1,158
Sally Khalifa, D.o, D.O
Family Medicine — Payments: $899.64